ArticleCardiovascular therapeutics2024

Dehydroevodiamine Alleviates Doxorubicin-Induced Cardiomyocyte Injury by Regulating Neuregulin-1/ErbB Signaling.

Song Jie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.